Live Breaking News & Updates on Benitec Biopharma Inc|Page 4

Stay updated with breaking news from Benitec biopharma inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Benitec Biopharma Inc. (NASDAQ:BNTC) Sees Significant Drop in Short Interest

Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) saw a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 6,200 shares, a decline of 18.4% from the December 31st total of 7,600 shares. Based on an average trading volume of 9,000 shares, the short-interest ratio […] ....

Benitec Biopharma , Benitec Biopharma Inc , Renaissance Technologies , Morgan Stanley , Virtu Financial , Millennium Management , Get Free Report , Adage Capital Partners , Biopharma Stock Down , Biopharma Inc , Benitec Biopharma Daily , Nasdaq Bntc ,

Benitec Biopharma (NASDAQ:BNTC) PT Raised to $8.00 at JMP Securities

Benitec Biopharma (NASDAQ:BNTC – Free Report) had its target price boosted by JMP Securities from $6.00 to $8.00 in a report released on Wednesday, Benzinga reports. The firm currently has a market outperform rating on the biotechnology company’s stock. Benitec Biopharma Trading Up 4.4 % NASDAQ:BNTC opened at $3.07 on Wednesday. The stock has a […] ....

Benitec Biopharma , Renaissance Technologies , Benitec Biopharma Inc , Virtu Financial , Millennium Management , Morgan Stanley , Free Report , Get Free Report , Adage Capital Partners , Biopharma Inc , Benitec Biopharma Daily , Nasdaq Bntc , Boost Price Target , Jmp Securities ,

JMP Securities Raises Benitec Biopharma (NASDAQ:BNTC) Price Target to $8.00

Benitec Biopharma (NASDAQ:BNTC – Get Free Report) had its price objective upped by equities research analysts at JMP Securities from $6.00 to $8.00 in a research report issued on Wednesday, Benzinga reports. The firm currently has a “market outperform” rating on the biotechnology company’s stock. JMP Securities’ price objective indicates a potential upside of 166.67% […] ....

Benitec Biopharma , Benitec Biopharma Inc , Virtu Financial , Morgan Stanley , Millennium Management , Renaissance Technologies , Get Free Report , Adage Capital Partners , Biopharma Inc , Benitec Biopharma Daily , Nasdaq Bntc , Boost Price Target , Jmp Securities ,

JMP Securities Raises Benitec Biopharma (NASDAQ:BNTC) Price Target to $8.00

JMP Securities Raises Benitec Biopharma (NASDAQ:BNTC) Price Target to $8.00
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Benitec Biopharma , Virtu Financial , Benitec Biopharma Inc , Renaissance Technologies , Millennium Management , Morgan Stanley , Get Free Report , Capital Partners , Biopharma Inc , Benitec Biopharma Daily ,

Benitec Biopharma Inc. (NASDAQ:BNTC) Short Interest Down 28.2% in November

Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) was the recipient of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 33,400 shares, a drop of 28.2% from the October 31st total of 46,500 shares. Currently, 1.5% of the company’s shares are sold short. […] ....

Benitec Biopharma , Morgan Stanley , Benitec Biopharma Company Profile , Renaissance Technologies , Millennium Management , Benitec Biopharma Inc , Virtu Financial , Get Free Report , Capital Partners , Biopharma Inc , Benitec Biopharma Daily , Nasdaq Bntc ,